Amarin Corp Plc (AMRN)

[rosemountbomber]

I am obviously quite dense when it comes to certain details concerning a possible new formulation. If you or anyone else wants to opine and educate us on these questions I would appreciate it and it may benefit all of us here:

1) What will the FDA require Amarin to do to be able to market a new formulation?
2) Will Amarin stop marketing the current formulation if permitted to market the new formulation?
3) Will Amarin be able to prevent Generics from selling this new formulation?
4) Will docs, pharmacies, insurance companies still divert scripts for the new formulation to whatever the Generics are selling?

I am postulating those questions as being for now strictly related to the U.S. market.